These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2966663)

  • 1. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.
    Itoh S; Takashima A; Igano K; Inouye K
    Peptides; 1989; 10(4):843-8. PubMed ID: 2531375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of V-9-M, a peptide fragment derived from procholecystokinin, on memory processes in the rat.
    Takashima A; Itoh S
    Can J Physiol Pharmacol; 1989 Mar; 67(3):228-31. PubMed ID: 2743209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unlike beta-endorphin, dynorphin 1-13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats.
    Izquierdo I; De Almeida MA; Emiliano VR
    Psychopharmacology (Berl); 1985; 87(2):216-8. PubMed ID: 2864714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular cholecystokinin infusions block beta-endorphin-induced disruption of maternal behavior.
    Felicio LF; Mann PE; Bridges RS
    Pharmacol Biochem Behav; 1991 May; 39(1):201-4. PubMed ID: 1924504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin octapeptide, proglumide, and passive avoidance in rats.
    Deupree D; Hsiao S
    Peptides; 1987; 8(1):25-8. PubMed ID: 3575151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular beta-endorphin in the rat.
    Suh HH; Collins KA; Tseng LF
    Neuropeptides; 1992 Mar; 21(3):131-7. PubMed ID: 1321361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala.
    Flood JF; Garland JS; Morley JE
    Brain Res; 1992 Jul; 585(1-2):94-104. PubMed ID: 1511338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of immunoreactive [Met5]enkephalin and cholecystokinin from the spinal cord by beta-endorphin administered intraventricularly in the pentobarbital-anesthetized rat.
    Tseng LF; Huang FY
    Eur J Pharmacol; 1992 May; 215(2-3):309-12. PubMed ID: 1396996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence on memory of posttraining or pre-test injections of ACTH, vasopressin, epinephrine, and beta-endorphin, and their interaction with naloxone.
    Izquierdo I; Dias RD
    Psychoneuroendocrinology; 1985; 10(2):165-72. PubMed ID: 2994140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.
    Itoh S; Katsuura G
    Jpn J Physiol; 1982; 32(4):667-75. PubMed ID: 6294391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice.
    Suh HH; Fujimoto JM; Tseng LL
    Eur J Pharmacol; 1989 Sep; 168(1):61-70. PubMed ID: 2531093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ACTH, epinephrine, beta-endorphin, naloxone, and of the combination of naloxone or beta-endorphin with ACTH or epinephrine on memory consolidation.
    Izquierdo I; Dias RD
    Psychoneuroendocrinology; 1983; 8(1):81-7. PubMed ID: 6308701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.